Solventum Q1 sales rise 2.6% to $2.1 billion, but GAAP EPS falls 43% to $0.78
Solventum reported first-quarter 2025 sales up 2.6% to $2.1 billion, with organic sales up 4.3%. Profit fell sharply: net income was $137 million versus $237 million a year earlier, and GAAP diluted EPS was $0.78 versus $1.37. The company raised its full-year 2025 organic sales growth outlook to +1.5% to +2.5% but left its adjusted EPS and free cash flow guidance unchanged.
Key points
- Net sales rose 2.6% to $2.1 billion; organic sales rose 4.3% for the quarter.
- GAAP diluted EPS was $0.78 versus $1.37; adjusted diluted EPS was $1.34 versus $2.08.
- Free cash flow was negative $80 million versus $340 million a year earlier.
- Full-year organic sales growth outlook raised to +1.5% to +2.5% from +1.0% to +2.0%; adjusted EPS guidance of $5.45 to $5.65 unchanged.
The filing
Written by AI on Nov 8, 2026, 1:11 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 08, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.